MS Society Trial Alert lists the MS Center as an enrolling site for the Ocrelizumab studies.

National MS Society website for MS Trial Alerts dated March 6, 2017 & December 14,2016 regarding Ocrelizumab lists the MS Center of Northeastern NY in Latham, NY as a center enrolling patients for the two trials, OBOE & CHORDS. We are the only center in the Capital region and beyond that has experience with Ocrelizumab. Click here for more information.